BioSpace News Archive

LabConnect Inc., a leading global provider of central laboratory and functional outsourcing services for biopharmaceutical, pharmaceutical, medical device, and contract research organizations, today announced that the company is expanding its operations into Europe with the appointment of Marc van Kempen as General Manager Europe.

Unravel Biosciences, Inc. (“Unravel”), today announced a partnership with TMA Precision Health (“TMA”), a Startup Health platform for rare diseases, aimed at identifying rare Rett Syndrome patients for inclusion in Unravel’s first-in-human reformulated drug trial.

Novavax, Inc. (Nasdaq: NVAX), today announced that the European Commission (EC) has approved the expanded conditional marketing authorization (CMA) of Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine in the European Union (EU) for adolescents aged 12 through 17.

Wearable Devices Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Wearable Devices market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years

Antibiotics Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Antibiotics market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.

Spinal Implants Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Spinal Implants market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years

DBMR released a report titled “Advanced Wound Care Market” which delivers detailed overview of the Advanced Wound Care market in terms of market segmentation by type, route of administration, end-user, and by region.

Stem Cell Therapy Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Stem Cell Therapy market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.

AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced new data indicating that ilofotase alfa protects against ischemia-reperfusion induced acute kidney injury (AKI) has been published in the journal, Frontiers in Medicine-Nephrology.

A recent report provides crucial insights along with application based and forecast information in the Global Basic Infusion Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market.